XML 133 R118.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidating Financial Information - Condensed Consolidating Statements of Cash Flows (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Jan. 17, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Consolidated Statements of Cash Flows [Abstract]        
Net cash provided by operating activities   $ 657.2 $ 634.4 $ 502.0
Cash flows from investing activities:        
Acquisition of businesses, net of cash acquired   (38.8) (48.1) (985.1)
Purchases of property and equipment   (225.8) (177.7) (128.4)
Additions to capitalized software costs   (19.2) (25.2) (28.1)
Proceeds from disposal of assets   12.3 23.9 4.0
Proceeds from sale of nonrestricted marketable securities   0.0 0.0 12.8
Purchase of restricted investments   (8.5) (1.3) (7.1)
Net change in restricted cash   (1.5) (15.1) 2.7
Funding of intercompany note receivable     0.0 0.0
Proceeds from repayment of intercompany note receivable   0.0 0.0 0.0
Other   (3.0) (1.6) (1.1)
Net cash provided by investing activities of discontinued operations   0.0 0.1 0.5
Net cash used in investing activities   (284.5) (245.0) (1,129.8)
Cash flows from financing activities:        
Principal borrowings on term loan facilities   0.0 0.0 250.0
Proceeds from bond issuance   0.0 0.0 1,400.0
Principal payments on debt, including pre-payments   (129.9) (202.1) (597.4)
Principal borrowings on intercompany notes payable     0.0 0.0
Principal payments on intercompany notes payable   0.0 0.0 0.0
Borrowings on revolving credit facility   273.3 335.0 540.0
Payments on revolving credit facility   (330.3) (313.0) (735.0)
Principal payments under capital lease obligations   (15.3) (13.3) (11.0)
Debt amendment and issuance costs   (3.1) 0.0 (31.9)
Repurchases of common stock, including fees and expenses   (38.1) (65.6) (45.3)
Dividends paid on common stock   (91.5) (83.8) (77.2)
Proceeds from exercising stock warrants $ 26.7 26.6 0.0 0.0
Distributions paid to noncontrolling interests of consolidated affiliates   (51.9) (64.9) (54.4)
Taxes paid on behalf of employees for shares withheld   (19.8) (11.6) (17.2)
Contributions from consolidated affiliates   20.8 3.5 3.0
Other   0.4 5.3 (0.9)
Change in intercompany advances   0.0 0.0 0.0
Net cash (used in) provided by financing activities   (358.8) (410.5) 622.7
Increase (decrease) in cash and cash equivalents   13.9 (21.1) (5.1)
Cash and cash equivalents at beginning of year 40.5 40.5 61.6 66.7
Cash and cash equivalents at end of year   54.4 40.5 61.6
Supplemental schedule of noncash financing activities:        
Conversion of convertible debt   319.4 0.0 0.0
Preferred stock conversion   0.0 0.0 93.2
Intercompany note activity       0.0
Eliminating Entries        
Consolidated Statements of Cash Flows [Abstract]        
Net cash provided by operating activities   0.0 0.0 0.0
Cash flows from investing activities:        
Acquisition of businesses, net of cash acquired   0.0 0.0 0.0
Purchases of property and equipment   0.0 0.0 0.0
Additions to capitalized software costs   0.0 0.0 0.0
Proceeds from disposal of assets   0.0 0.0 0.0
Proceeds from sale of nonrestricted marketable securities       0.0
Purchase of restricted investments   0.0 0.0 0.0
Net change in restricted cash   0.0 0.0 0.0
Funding of intercompany note receivable     22.5 2.0
Proceeds from repayment of intercompany note receivable   (51.0) (52.0) (24.0)
Other   0.0 0.0 0.0
Net cash provided by investing activities of discontinued operations     0.0 0.0
Net cash used in investing activities   (51.0) (29.5) (22.0)
Cash flows from financing activities:        
Principal borrowings on term loan facilities       0.0
Proceeds from bond issuance       0.0
Principal payments on debt, including pre-payments   0.0 0.0 0.0
Principal borrowings on intercompany notes payable     (22.5) (2.0)
Principal payments on intercompany notes payable   51.0 52.0 24.0
Borrowings on revolving credit facility   0.0 0.0 0.0
Payments on revolving credit facility   0.0 0.0 0.0
Principal payments under capital lease obligations   0.0 0.0 0.0
Debt amendment and issuance costs   0.0   0.0
Repurchases of common stock, including fees and expenses   0.0 0.0 0.0
Dividends paid on common stock   0.0 0.0 0.0
Proceeds from exercising stock warrants   0.0    
Distributions paid to noncontrolling interests of consolidated affiliates   0.0 0.0 0.0
Taxes paid on behalf of employees for shares withheld   0.0 0.0 0.0
Contributions from consolidated affiliates   0.0 0.0 0.0
Other   0.0 0.0 0.0
Change in intercompany advances   0.0 0.0 0.0
Net cash (used in) provided by financing activities   51.0 29.5 22.0
Increase (decrease) in cash and cash equivalents   0.0 0.0 0.0
Cash and cash equivalents at beginning of year 0.0 0.0 0.0 0.0
Cash and cash equivalents at end of year   0.0 0.0 0.0
Supplemental schedule of noncash financing activities:        
Conversion of convertible debt   0.0    
Preferred stock conversion       0.0
Intercompany note activity       0.0
Encompass Health Corporation        
Consolidated Statements of Cash Flows [Abstract]        
Net cash provided by operating activities   27.6 65.8 59.7
Cash flows from investing activities:        
Acquisition of businesses, net of cash acquired   (10.9) 0.0 (954.6)
Purchases of property and equipment   (39.4) (21.8) (15.9)
Additions to capitalized software costs   (16.3) (22.8) (24.5)
Proceeds from disposal of assets   0.0 0.0 0.0
Proceeds from sale of nonrestricted marketable securities       12.8
Purchase of restricted investments   0.0 0.0 0.0
Net change in restricted cash   0.0 0.0 0.0
Funding of intercompany note receivable     (22.5) (2.0)
Proceeds from repayment of intercompany note receivable   51.0 52.0 24.0
Other   (3.7) (3.7) (0.5)
Net cash provided by investing activities of discontinued operations     0.1 0.5
Net cash used in investing activities   (19.3) (18.7) (960.2)
Cash flows from financing activities:        
Principal borrowings on term loan facilities       250.0
Proceeds from bond issuance       1,400.0
Principal payments on debt, including pre-payments   (126.9) (198.5) (595.0)
Principal borrowings on intercompany notes payable     0.0 0.0
Principal payments on intercompany notes payable   0.0 0.0 0.0
Borrowings on revolving credit facility   273.3 335.0 540.0
Payments on revolving credit facility   (330.3) (313.0) (735.0)
Principal payments under capital lease obligations   0.0 (0.1) (0.3)
Debt amendment and issuance costs   (3.1)   (31.9)
Repurchases of common stock, including fees and expenses   (38.1) (65.6) (45.3)
Dividends paid on common stock   (91.5) (83.8) (77.2)
Proceeds from exercising stock warrants   26.6    
Distributions paid to noncontrolling interests of consolidated affiliates   0.0 0.0 0.0
Taxes paid on behalf of employees for shares withheld   (19.5) (11.6) (17.2)
Contributions from consolidated affiliates   0.0 0.0 0.0
Other   1.1 6.9 (0.9)
Change in intercompany advances   313.8 263.0 212.6
Net cash (used in) provided by financing activities   5.4 (67.7) 899.8
Increase (decrease) in cash and cash equivalents   13.7 (20.6) (0.7)
Cash and cash equivalents at beginning of year 20.6 20.6 41.2 41.9
Cash and cash equivalents at end of year   34.3 20.6 41.2
Supplemental schedule of noncash financing activities:        
Conversion of convertible debt   319.4    
Preferred stock conversion       93.2
Intercompany note activity       (183.5)
Guarantor Subsidiaries        
Consolidated Statements of Cash Flows [Abstract]        
Net cash provided by operating activities   381.3 327.4 214.6
Cash flows from investing activities:        
Acquisition of businesses, net of cash acquired   0.0 0.0 0.0
Purchases of property and equipment   (106.1) (77.4) (62.0)
Additions to capitalized software costs   (0.2) (0.2) (0.4)
Proceeds from disposal of assets   11.7 0.7 3.5
Proceeds from sale of nonrestricted marketable securities       0.0
Purchase of restricted investments   0.0 0.0 0.0
Net change in restricted cash   0.0 0.0 0.0
Funding of intercompany note receivable     0.0 0.0
Proceeds from repayment of intercompany note receivable   0.0 0.0 0.0
Other   0.0 (0.2) (1.9)
Net cash provided by investing activities of discontinued operations     0.0 0.0
Net cash used in investing activities   (94.6) (77.1) (60.8)
Cash flows from financing activities:        
Principal borrowings on term loan facilities       0.0
Proceeds from bond issuance       0.0
Principal payments on debt, including pre-payments   0.0 (1.3) (1.6)
Principal borrowings on intercompany notes payable     0.0 0.0
Principal payments on intercompany notes payable   0.0 0.0 0.0
Borrowings on revolving credit facility   0.0 0.0 0.0
Payments on revolving credit facility   0.0 0.0 0.0
Principal payments under capital lease obligations   (6.8) (5.9) (4.5)
Debt amendment and issuance costs   0.0   0.0
Repurchases of common stock, including fees and expenses   0.0 0.0 0.0
Dividends paid on common stock   0.0 0.0 0.0
Proceeds from exercising stock warrants   0.0    
Distributions paid to noncontrolling interests of consolidated affiliates   0.0 0.0 0.0
Taxes paid on behalf of employees for shares withheld   0.0 0.0 0.0
Contributions from consolidated affiliates   0.0 0.0 0.0
Other   0.0 0.0 1.5
Change in intercompany advances   (278.6) (242.7) (149.4)
Net cash (used in) provided by financing activities   (285.4) (249.9) (154.0)
Increase (decrease) in cash and cash equivalents   1.3 0.4 (0.2)
Cash and cash equivalents at beginning of year 1.6 1.6 1.2 1.4
Cash and cash equivalents at end of year   2.9 1.6 1.2
Supplemental schedule of noncash financing activities:        
Conversion of convertible debt   0.0    
Preferred stock conversion       0.0
Intercompany note activity       0.0
Non-Guarantor Subsidiaries        
Consolidated Statements of Cash Flows [Abstract]        
Net cash provided by operating activities   248.3 241.2 227.7
Cash flows from investing activities:        
Acquisition of businesses, net of cash acquired   (27.9) (48.1) (30.5)
Purchases of property and equipment   (80.3) (78.5) (50.5)
Additions to capitalized software costs   (2.7) (2.2) (3.2)
Proceeds from disposal of assets   0.6 23.2 0.5
Proceeds from sale of nonrestricted marketable securities       0.0
Purchase of restricted investments   (8.5) (1.3) (7.1)
Net change in restricted cash   (1.5) (15.1) 2.7
Funding of intercompany note receivable     0.0 0.0
Proceeds from repayment of intercompany note receivable   0.0 0.0 0.0
Other   0.7 2.3 1.3
Net cash provided by investing activities of discontinued operations     0.0 0.0
Net cash used in investing activities   (119.6) (119.7) (86.8)
Cash flows from financing activities:        
Principal borrowings on term loan facilities       0.0
Proceeds from bond issuance       0.0
Principal payments on debt, including pre-payments   (3.0) (2.3) (0.8)
Principal borrowings on intercompany notes payable     22.5 2.0
Principal payments on intercompany notes payable   (51.0) (52.0) (24.0)
Borrowings on revolving credit facility   0.0 0.0 0.0
Payments on revolving credit facility   0.0 0.0 0.0
Principal payments under capital lease obligations   (8.5) (7.3) (6.2)
Debt amendment and issuance costs   0.0   0.0
Repurchases of common stock, including fees and expenses   0.0 0.0 0.0
Dividends paid on common stock   0.0 0.0 0.0
Proceeds from exercising stock warrants   0.0    
Distributions paid to noncontrolling interests of consolidated affiliates   (51.9) (64.9) (54.4)
Taxes paid on behalf of employees for shares withheld   (0.3) 0.0 0.0
Contributions from consolidated affiliates   20.8 3.5 3.0
Other   (0.7) (1.6) (1.5)
Change in intercompany advances   (35.2) (20.3) (63.2)
Net cash (used in) provided by financing activities   (129.8) (122.4) (145.1)
Increase (decrease) in cash and cash equivalents   (1.1) (0.9) (4.2)
Cash and cash equivalents at beginning of year $ 18.3 18.3 19.2 23.4
Cash and cash equivalents at end of year   17.2 $ 18.3 19.2
Supplemental schedule of noncash financing activities:        
Conversion of convertible debt   $ 0.0    
Preferred stock conversion       0.0
Intercompany note activity       $ 183.5